These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1319727)

  • 1. Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.
    Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Morikage T; Fujiwara Y; Saijo N
    Br J Cancer; 1992 Jun; 65(6):857-64. PubMed ID: 1319727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP).
    Ohmori T; Nishio K; Ohta S; Kubota N; Adachi M; Komiya K; Saijo N
    Int J Cancer; 1994 Apr; 57(1):111-6. PubMed ID: 8150528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
    Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
    Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
    Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.
    Hong WS; Saijo N; Sasaki Y; Minato K; Nakano H; Nakagawa K; Fujiwara Y; Nomura K; Twentyman PR
    Int J Cancer; 1988 Mar; 41(3):462-7. PubMed ID: 3346112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP.
    Nishio K; Morikage T; Kubota N; Ohmori T; Takeda Y; Fujiwara Y; Miki K; Abe K; Saijo N
    Jpn J Cancer Res; 1992 Jul; 83(7):754-60. PubMed ID: 1325432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line.
    Oshita F; Fujiwara Y; Saijo N
    J Cancer Res Clin Oncol; 1992; 119(1):28-34. PubMed ID: 1400562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.
    Kasahara K; Fujimura M; Bando T; Shibata K; Shirasaki H; Matsuda T
    Br J Cancer; 1996 Nov; 74(10):1553-8. PubMed ID: 8932334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
    Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL
    Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.
    Bungo M; Fujiwara Y; Kasahara K; Nakagawa K; Ohe Y; Sasaki Y; Irino S; Saijo N
    Cancer Res; 1990 May; 50(9):2549-53. PubMed ID: 2158392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased phosphorylation of nuclear phosphoproteins in human lung-cancer cells resistant to cis-diamminedichloroplatinum (II).
    Nishio K; Sugimoto Y; Kasahara K; Fujiwara Y; Nishiwaki S; Fujiki H; Ohata M; Saijo N
    Int J Cancer; 1992 Feb; 50(3):438-42. PubMed ID: 1310490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line.
    Nakagawa M; Nomura Y; Kohno K; Ono M; Mizoguchi H; Ogata J; Kuwano M
    J Urol; 1993 Dec; 150(6):1970-3. PubMed ID: 8230547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
    Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
    Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP.
    Zhan M; Liu X
    Chin Med J (Engl); 1999 Apr; 112(4):336-9. PubMed ID: 11593534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and biochemical properties of cis-diamminedichloroplatinum(II)-resistant A549 lung cancer cells.
    Yamauchi N; Shiotani T; Yamaji Y; Fujita J; Hata Y; Irino S
    Cancer Biochem Biophys; 1991 Nov; 12(3):177-83. PubMed ID: 1844910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.